The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase

Toxicology and Applied Pharmacology

Volumn 145, Issue 1, 1997, Pages 43-53

  Raveh, Lily ^a   Grauer, Ettie ^a   Grunwald, Jacob ^a   Cohen, E ^b   Ashani, Yacov ^a  

^a ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDOTE; CHOLINESTERASE; METHYLPHOSPHONOTHIOIC ACID S (2 DIISOPROPYLAMINOETHYL) O ETHYL ESTER; SOMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; BIOAVAILABILITY; CONTROLLED STUDY; DRUG EFFICACY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; RHESUS MONKEY; SPATIAL DISCRIMINATION; STOICHIOMETRY; TOXICITY;

ANIMALIA; MACACA MULATTA;

EID: 0031193319     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8160     Document Type: Article

References (37)

1. Ashani Y., Shapira S., Levy D., Wolfe A. D., Doctor B. P., Raveh L. Butyrylcholinesterase and acetylcholinesterase prophylaxis against soman poisoning in mice. Biochem. Pharmacol. 41:1991;37-41.
2. Benschop H. P., De Jong L. Toxicokinetics of soman: Species variation and stereospecificity in elimination pathways. Neurosci. Biobehav. Rev. 15:1991;73-77.
3. Blick D. W., Murphy M. R., Brown G. C., Yochmowitz M. G., Fanton J. W., Hartgraves S. L. Acute behavioral toxicity of pyridostigmine or soman in primates. Toxicol. Appl. Pharmacol. 126:1994;311-318.
4. Brandeis R., Raveh L., Grunwald J., Cohen E., Ashani Y. Prevention of soman-induced cognitive deficits by pretreatment with human butyrylcholinesterase in rats. Pharmacol. Biochem. Behav. 46:1993;889-896.
5. Broomfield C. A., Maxwell D. M., Solana R. P., Castro C. A., Finger A. V., Lenz D. E. Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates. J. Pharmacol. Exp. Ther. 259:1991;633-638.
6. Cascio C., Comite C., Ghiara M., Lanza G., Ponchione A. The use of serum cholinesterase in severe phosphorus poisoning. Minerva Anestesiol. (Italian). 54:1988;337-338.
7. Castro C. A., Larsen T., Finger A. V., Solana R. P., McMaster S. B. Behavioral efficacy of diazepam against nerve agent exposure in rhesus monkeys. Pharmacol. Biochem. Behav. 41:1991;159-164.
8. Castro C. A., Gresham V. C., Finger A. V., Maxwell D. M., Solana R. P., Lenz D. E., Broomfield C. V. Behavioral decrements persist in rhesus monkeys trained on a serial probe recognition task despite protection against soman lethality by Butyrylcholinesterase. Neurotoxicol. Teratol. 16:1994;45-148.
9. Dirnhuber P., French M. C., Green D. M., Leadbeater L., Startton J. A. The protection of primates against soman poisoning by pretreatment with pyridostigmine. J. Pharm. Pharmacol. 31:1979;295-299.
10. D'Mello G. D. Behavioral toxicity of anticholinesterases in humans and animals - A review. Hum. Exp. Toxicol. 12:1993;3-7.
11. Doctor B. P., Raveh L., Wolfe A. D., Maxwell D. M., Ashani Y. Enzymes as pretreatment drugs for organophosphate poisoning. Neurosci. Biobehav. Rev. 15:1991;123-128.
12. Dunn M. A., Sidell F. R. Progress in medical defense against nerve agents. J. Am. Med. Assoc. 262:1989;649-652.
13. Ellman G. L., Courtney K. D., Andres V. Jr., Featherstone R. M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:1961;88-95.
14. Gause E. M., Hartmann R. J., Leal B., Geller I. Neurobehavioral effects of repeated sublethal soman in primates. Pharmacol. Biochem. Behav. 23:1985;1003-1012.
15. Geller I., Hartmenn R. J., Moran E., Leal B. Z., Haines R. J., Gause E. M. Acute soman effects in the juvenile baboon: Effects on matching-to-sample discrimination task and on total blood acetylcholinesterase. Pharmacol. Biochem. Behav. 22:1985;961-966.
16. Gibaldi M., Perrier D. Pharmkocinetics. 1982.
17. Jenkins T., Balinski D., Patient D. W. Cholinesterase in plasma: First reported absence in the Bantu; Half-life determination. Science. 156:1967;1748-1750.
18. W. M. Kluwe, J. C. Chinn, P. Feder, C. Olson, R. Joiner, 1987, Efficacy of pyridostigmine pretreatment against acute soman intoxication in a primate model, Proceedings of the Sixth Medical Defense Bioscience Review, 227, 234, U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD.
19. Lainee P., Robineau P., Guittin P., Coq H., Benchetrit G. Mechanism of pulmonary edema induced by an organophosphorus compound in anaesthetized dogs. Fundam. Appl. Toxicol. 17:1991;177-185.
20. Levine H., Rodnitzky R. L. Behavioral effects of organophosphate pesticide in man. Clin. Toxicol. 9:1976;391-405.
21. Maxwell D. M. The specificity of carboxylesterases protection against the toxicity of organophosphorus compounds. Toxicol. Appl. Pharmacol. 114:1992;306-312.
22. Maxwell D. M., Brecht K. M. The role of carboxylesterases in species variation of oxime protection against soman. Neurosci. Behav. Rev. 15:1991;135-139.
23. Maxwell D. M., Castro C. A., De La Hoz D. M., Gentry M. K., Gold M. B., Solana R. P., Wolfe A. D., Doctor B. P. Protection of Rhesus monkeys against soman and prevention of performance decrement by pretreatment with acetylcholinesterase. Toxicol. Appl. Pharmacol. 115:1992;44-49.
24. McDonough J. M., Shih T-M. Pharmacological modulation of soman-induced seizures. Neurosci. Behav. Rev. 17:1993;203-215.
25. Metcalf D. R., Holmes J. H. EEG, psychological and neurological alterations in humans with organophosphorus exposure. Ann. NY Acad. Sci. 160:1969;357-365.
26. Olton D. S., Becker J. T., Handelmann G. E. Hippocampal function: Working memory or cognitive mapping? Physiol. Psychol. 8:1980;239-246.
27. Ostergaard D., Viby-Mogensen J., Hanel H. K., Skovgaard L. T. Half-life of plasma cholinesterase. Acta. Anaesth. Scand. 32:1988;266-269.
28. Raveh L., Ashani Y., Levy D., De La Hoz D., Wolfe A. D., Doctor B. P. Acetylcholinesterase prophylaxis against organophosphate poisoning: Quantitative correlation between protection and blood-enzyme level in mice. Biochem. Pharmacol. 38:1989;529-534.
29. Raveh L., Grunwald J., Marcus D., Papier Y., Cohen E., Ashani Y. Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity: In vitro and in vivo quantitative characterization. Biochem. Pharmacol. 45:1993;2465-2474.
30. Rickett D. L., Glenn J. F., Beers E. T. Central respiratory effects versus neuromuscular actions of nerve agents. Neurotoxicology. 7:1986;225-236.
31. Sidell F. R. Soman and sarin clinical manifestations and treatment of accidental poisoning by organophosphates. Clin. Toxicol. 7:1974;1-17.
32. Shih T-M. Cholinergic actions of diazepam and atropine sulfate in soman poisoning. Brain Res. Bull. 26:1991;565-573.
33. Shih T-M., Koviak T. A., Capacio B. R. Anticonvulsants for poisoning by the organophosphorus compound soman: Pharmacological mechanism. Neurosci. Biobehav. Rev. 15:1991;349-362.
34. Stovner J., Stadskleiv K. Suxamethonium apnoea terminated with commercial serumcholinesterase. Acta. Anaesth. Scand. 20:1976;211-215.
35. Wolfe A. D., Rush R. S., Doctor B. P., Jones D. Acetylcholinesterase prophylaxis against organophosphate. Toxicity Fundam. Appl. Toxicol. 9:1987;266-270.
36. Wolfe A. D., Blick D. W., Murphy R. M., Miller S. A., Gentry M. K., Hartgraves S. L., Doctor B. P. Use of cholinesterases as pretreatment drugs for the protection of rhesus monkeys against soman toxicity. Toxicol. Appl. Pharmacol. 117:1992;189-193.
37. Wolfenshon S. E., Lloyd M. H. A Handbook of Laboratory Animal Management and Welfare. 1994;Oxford Univ. Press.